Skip to main content
. 2011 May;7(3 Suppl):e30s–e37s. doi: 10.1200/JOP.2011.000302

Figure 1.

Figure 1.

Share of each first-line regimen for (A) preperiod cohort (January 1, 2002, to December 31, 2002) and (B) postperiod cohort (June 1, 2004, to May 31, 2005). FOLFIRI, fluorouracil plus irinotecan; FOLFOX, fluorouracil/leucovorin with oxaliplatin; FU, fluorouracil; IFL, fluorouracil plus irinotecan; LV, leucovorin.